Frazier Life Sciences manages investments exclusively for U.S. private investment funds, focusing on companies that develop and commercialize novel therapeutics. Frazier Life Sciences evaluates pharmaceutical and biotechnology companies at all stages, from formation to public offerings, globally. The firm's services include identifying investment opportunities, structuring investments, managing performance, and exiting investments. Frazier Life Sciences may also offer opportunities for investors to co-invest in portfolio companies.
Fee Structure
Frazier Life Sciences does not directly manage investments for individual investors. The firm manages investments for private investment funds, charging a management fee typically based on a percentage of the fund's capital commitments. The fee percentage may vary depending on the fund's size and may decrease over time. A related party of Frazier Life Sciences also receives a share of capital gains or appreciation, known as carried interest.